How many institutions held CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share in Q1 2020?

72 institutional investors reported CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share for Q1 2020. Use the holders table for investor-level position and value details.

Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)

Q: What does CUSIP 22978P106 represent in this 13F holders report?

CUSIP 22978P106 is the security identifier for CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

CUSIP: 22978P106

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 43,411,663
Total 13F shares: 13,033,369
Share change: +2,589,484
Total reported value: $184,956,981
Price per share: $14.19
Number of holders: 72
Value change: +$36,613,314
Number of buys: 39
Number of sells: 18

Quarterly Holders Quick Answers

What is CUSIP 22978P106?
CUSIP 22978P106 identifies CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP 22978P106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Avoro Capital Advisors LLC	13F	Company	4.3%	1,870,000	$29,686,000	—	31 Dec 2019	13F
Nantahala Capital Management, LLC	13F	Company	3.2%	1,404,941	$22,303,000	—	31 Dec 2019	13F
BlackRock Finance, Inc.	13F	Company	3.2%	1,387,669	$22,029,000	—	31 Dec 2019	13F
Slate Path Capital LP	13F	Company	2.1%	890,000	$14,129,000	—	31 Dec 2019	13F
VANGUARD GROUP INC	13F	Company	2%	889,716	$14,125,000	—	31 Dec 2019	13F
MANGROVE PARTNERS IM, LLC	13F	Company	1.4%	601,398	$9,547,000	—	31 Dec 2019	13F
STATE STREET CORP	13F	Company	0.77%	333,701	$5,298,000	—	31 Dec 2019	13F
683 Capital Management, LLC	13F	Company	0.74%	320,000	$5,080,000	—	31 Dec 2019	13F
Corriente Advisors, LLC	13F	Company	0.66%	285,000	$4,524,000	—	31 Dec 2019	13F
Crestwood Advisors Group, LLC	13F	Company	0.62%	270,000	$4,286,000	—	31 Dec 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.61%	263,206	$4,178,000	—	31 Dec 2019	13F
NORTHERN TRUST CORP	13F	Company	0.51%	220,073	$3,493,000	—	31 Dec 2019	13F
PRECEPT MANAGEMENT LLC	13F	Company	0.39%	170,000	$2,700,000	—	31 Dec 2019	13F
Bleichroeder LP	13F	Company	0.38%	165,000	$2,619,000	—	31 Dec 2019	13F
Prosight Management, LP	13F	Company	0.32%	137,628	$2,185,000	—	31 Dec 2019	13F
Nuveen Asset Management, LLC	13F	Company	0.3%	130,779	$2,077,000	—	31 Dec 2019	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	0.21%	92,728	$1,472,000	—	31 Dec 2019	13F
Voss Capital, LP	13F	Company	0.21%	92,500	$1,469,000	—	31 Dec 2019	13F
MORGAN STANLEY	13F	Company	0.18%	76,028	$1,207,000	—	31 Dec 2019	13F
SANDERS MORRIS HARRIS LLC	13F	Company	0.16%	69,750	$1,138,000	—	31 Dec 2019	13F
Bank of New York Mellon Corp	13F	Company	0.15%	66,282	$1,052,000	—	31 Dec 2019	13F
Sigma Planning Corp	13F	Company	0.15%	65,360	$1,038,000	—	31 Dec 2019	13F
Invesco Ltd.	13F	Company	0.14%	58,994	$937,000	—	31 Dec 2019	13F
UBS Group AG	13F	Company	0.14%	58,823	$933,000	—	31 Dec 2019	13F
STIFEL FINANCIAL CORP	13F	Company	0.13%	55,855	$887,000	—	31 Dec 2019	13F
Russell Investments Group, Ltd.	13F	Company	0.12%	52,233	$828,000	—	31 Dec 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.12%	50,192	$797,000	—	31 Dec 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.1%	43,393	$689,000	—	31 Dec 2019	13F
Rock Creek Group, LP	13F	Company	0.09%	37,500	$595,000	—	31 Dec 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.07%	31,266	$496,000	—	31 Dec 2019	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.07%	30,549	$485,000	—	31 Dec 2019	13F
HSBC HOLDINGS PLC	13F	Company	0.07%	30,282	$473,000	—	31 Dec 2019	13F
STRS OHIO	13F	Company	0.06%	28,200	$447,000	—	31 Dec 2019	13F
RHUMBLINE ADVISERS	13F	Company	0.06%	24,206	$384,000	—	31 Dec 2019	13F
WESTWOOD HOLDINGS GROUP INC	13F	Company	0.05%	20,700	$329,000	—	31 Dec 2019	13F
BARCLAYS PLC	13F	Company	0.05%	19,957	$317,000	—	31 Dec 2019	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.04%	18,800	$298,000	—	31 Dec 2019	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.04%	18,092	$287,000	—	31 Dec 2019	13F
Leap Investments LP	13F	Company	0.03%	15,173	$241,000	—	31 Dec 2019	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.03%	14,000	$222,000	—	31 Dec 2019	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.03%	13,511	$214,000	—	31 Dec 2019	13F
D. E. Shaw & Co., Inc.	13F	Company	0.03%	12,908	$205,000	—	31 Dec 2019	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.03%	12,500	$198,000	—	31 Dec 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.03%	12,247	$194,000	—	31 Dec 2019	13F
DOHENY ASSET MANAGEMENT /CA	13F	Company	0.03%	12,160	$193,000	—	31 Dec 2019	13F
FEDERATED HERMES, INC.	13F	Company	0.03%	10,962	$174,000	—	31 Dec 2019	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.02%	10,514	$167,000	—	31 Dec 2019	13F
MetLife Investment Management, LLC	13F	Company	0.02%	10,006	$158,845	—	31 Dec 2019	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.02%	8,873	$141,000	—	31 Dec 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.02%	7,244	$114,000	—	31 Dec 2019	13F

Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q1 2020

As of 31 Mar 2020, Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by 72 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,033,369 shares. The largest 10 holders included Nantahala Capital Management, LLC, Avoro Capital Advisors LLC, BlackRock Inc., VANGUARD GROUP INC, Slate Path Capital LP, Corriente Advisors, LLC, MANGROVE PARTNERS, Prosight Management, LP, STATE STREET CORP, and 683 Capital Management, LLC. This page lists 72 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders

Q1 2020 holders

Holder diff

Investor	Q4 2019 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q4 2019 Value $	Q1 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.